CEFAZOLIN

CEFAZOLIN was reported 12206 times

CEFAZOLIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 72 0.4706
1 THYMUS HYPOPLASIA 71 0.4080
2 MULTIPLE LENTIGINES SYNDROME 10 0.2632
3 HYPOPROTHROMBINAEMIA 55 0.1827
4 PERICARDITIS FUNGAL 12 0.1818
5 DISSEMINATED ASPERGILLOSIS 67 0.1419
6 GASTRITIS FUNGAL 12 0.1165
7 MYCOBACTERIAL PERITONITIS 11 0.1158
8 VITAMIN K DEFICIENCY 34 0.0846
9 POST PROCEDURAL HYPOTENSION 7 0.0824
10 ARTHRODESIS 70 0.0688
11 MYCOBACTERIUM FORTUITUM INFECTION 12 0.0649
12 RECURRENCE OF NEUROMUSCULAR BLOCKADE 11 0.0643
13 POST EMBOLISATION SYNDROME 7 0.0609
14 CHORIOAMNIONITIS 11 0.0579
15 AIRWAY PEAK PRESSURE INCREASED 8 0.0526
16 VANCOMYCIN INFUSION REACTION 19 0.0504
17 NORMAL LABOUR 7 0.0500
18 INCISION SITE INFECTION 44 0.0485
19 MENINGITIS FUNGAL 10 0.0426
20 CLOSTRIDIUM TEST POSITIVE 81 0.0367
21 HERPES DERMATITIS 7 0.0347
22 KOUNIS SYNDROME 70 0.0308
23 PARENTERAL NUTRITION 7 0.0303
24 MATERNAL EXPOSURE DURING DELIVERY 30 0.0303
25 HERPES SIMPLEX HEPATITIS 7 0.0292
26 IMPLANT SITE HAEMATOMA 7 0.0287
27 PYROGLUTAMIC ACIDOSIS 11 0.0277
28 ALLERGIC OEDEMA 17 0.0262
29 PROCEDURAL HYPOTENSION 22 0.0259
30 FOETAL EXPOSURE DURING DELIVERY 17 0.0251
31 SPINAL CORD OEDEMA 9 0.0243
32 EYE ABSCESS 7 0.0230
33 CIRCUMORAL OEDEMA 8 0.0229
34 TRYPTASE INCREASED 16 0.0224
35 URTICARIAL VASCULITIS 11 0.0208
36 LINEAR IGA DISEASE 32 0.0192
37 HYPERTHERMIA MALIGNANT 27 0.0181
38 DELAYED RECOVERY FROM ANAESTHESIA 17 0.0179
39 DISSEMINATED MUCORMYCOSIS 7 0.0178
40 DIABETIC RETINAL OEDEMA 9 0.0177
41 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 130 0.0167
42 DELIVERY 11 0.0167
43 CARDIAC VALVE VEGETATION 8 0.0165
44 CATARACT SUBCAPSULAR 10 0.0164
45 CYTOMEGALOVIRUS VIRAEMIA 72 0.0162
46 NECROTISING OESOPHAGITIS 8 0.0160
47 RED MAN SYNDROME 14 0.0159
48 TOXIC SHOCK SYNDROME 10 0.0159
49 DYSBIOSIS 13 0.0158
50 SCEDOSPORIUM INFECTION 11 0.0156
51 BRONCHOSTENOSIS 8 0.0146
52 EPISCLERITIS 10 0.0145
53 CLOSTRIDIUM DIFFICILE COLITIS 152 0.0143
54 ENDOCARDITIS STAPHYLOCOCCAL 7 0.0142
55 DELAYED GRAFT FUNCTION 10 0.0141
56 AMNIOTIC CAVITY INFECTION 10 0.0138
57 SHOULDER ARTHROPLASTY 37 0.0137
58 ANAPHYLACTIC SHOCK 354 0.0137
59 IRREGULAR BREATHING 8 0.0136
60 POST PROCEDURAL HAEMATOMA 23 0.0136
61 FUNGAEMIA 21 0.0133
62 ADRENAL SUPPRESSION 11 0.0130
63 HYPOVITAMINOSIS 17 0.0128
64 MYCOPLASMA INFECTION 10 0.0128
65 LARYNGEAL DISCOMFORT 8 0.0126
66 PSEUDOMONAL SEPSIS 22 0.0125
67 ACINETOBACTER INFECTION 13 0.0119
68 MALIGNANT HYPERTENSION 10 0.0116
69 DIABETES INSIPIDUS 28 0.0116
70 BRAIN HERNIATION 34 0.0114
71 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 12 0.0113
72 STAPHYLOCOCCAL BACTERAEMIA 49 0.0113
73 RASH MORBILLIFORM 31 0.0112
74 STRONGYLOIDIASIS 18 0.0111
75 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 14 0.0109
76 HYPERPARATHYROIDISM SECONDARY 27 0.0108
77 SKIN TEST POSITIVE 10 0.0107
78 PSEUDOMONAL BACTERAEMIA 9 0.0105
79 ANAESTHETIC COMPLICATION 28 0.0104
80 RENAL VEIN THROMBOSIS 7 0.0104
81 EMPYEMA 20 0.0101
82 SJS-TEN OVERLAP 7 0.0100
83 TINEA INFECTION 11 0.0100
84 PROPOFOL INFUSION SYNDROME 7 0.0099
85 NEPHROGENIC ANAEMIA 46 0.0099
86 SEPSIS NEONATAL 8 0.0099
87 KLEBSIELLA SEPSIS 11 0.0098
88 EOSINOPHILIC MYOCARDITIS 7 0.0096
89 TRANSFUSION REACTION 8 0.0091
90 ANAPHYLACTIC REACTION 498 0.0090
91 INTRAVENTRICULAR HAEMORRHAGE 22 0.0088
92 CHRONIC SPONTANEOUS URTICARIA 10 0.0086
93 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 7 0.0086
94 GLOMERULAR FILTRATION RATE ABNORMAL 12 0.0085
95 BRADYCARDIA FOETAL 7 0.0084
96 SEPTIC EMBOLUS 7 0.0084
97 TYPE I HYPERSENSITIVITY 28 0.0079
98 INTENSIVE CARE 11 0.0077
99 PRIMARY SEQUESTRUM 7 0.0077
100 GAZE PALSY 13 0.0076
101 SKIN GRAFT 7 0.0075
102 HEPARIN-INDUCED THROMBOCYTOPENIA 37 0.0075
103 BRONCHOSPASM 107 0.0075
104 MULTI-ORGAN FAILURE 129 0.0075
105 DEVICE RELATED SEPSIS 15 0.0074
106 ACTINOMYCOSIS 7 0.0073
107 LIMB OPERATION 35 0.0073
108 PULSELESS ELECTRICAL ACTIVITY 30 0.0072
109 VASCULAR PURPURA 10 0.0072
110 FEAR OF DEATH 16 0.0071
111 OTOTOXICITY 13 0.0070
112 PELVIC VENOUS THROMBOSIS 10 0.0070
113 CONJUNCTIVAL OEDEMA 7 0.0068
114 CATHETER SITE HAEMORRHAGE 17 0.0068
115 PSEUDOMEMBRANOUS COLITIS 15 0.0067
116 TYPE IV HYPERSENSITIVITY REACTION 18 0.0066
117 FEAR 176 0.0065
118 RENAL INJURY 194 0.0065
119 STRIDOR 19 0.0065
120 OSTEOSCLEROSIS 10 0.0063
121 RETROPERITONEAL HAEMATOMA 14 0.0063
122 NECROTISING COLITIS 8 0.0063
123 TINEA PEDIS 10 0.0063
124 LABELLED DRUG-DRUG INTERACTION ISSUE 9 0.0062
125 HAEMODYNAMIC INSTABILITY 47 0.0062
126 CARDIOVASCULAR INSUFFICIENCY 10 0.0061
127 HYPERSENSITIVITY VASCULITIS 16 0.0061
128 ANHEDONIA 159 0.0060
129 LYMPHOPENIA 85 0.0060
130 COAGULOPATHY 100 0.0060
131 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 13 0.0059
132 INFECTIOUS PLEURAL EFFUSION 9 0.0059
133 HAEMOTHORAX 17 0.0059
134 COMPLICATIONS OF TRANSPLANTED KIDNEY 13 0.0057
135 ENDOCARDITIS 29 0.0056
136 IMPLANT SITE INFECTION 13 0.0056
137 RESPIRATORY ALKALOSIS 9 0.0055
138 CUTANEOUS VASCULITIS 20 0.0055
139 NODAL RHYTHM 8 0.0055
140 CALCIPHYLAXIS 10 0.0054
141 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 18 0.0054
142 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 139 0.0054
143 CHOLESTATIC LIVER INJURY 12 0.0054
144 NEONATAL RESPIRATORY DISTRESS SYNDROME 19 0.0054
145 ARTHRITIS BACTERIAL 22 0.0054
146 RESPIRATORY ACIDOSIS 21 0.0053
147 CYSTOID MACULAR OEDEMA 10 0.0053
148 TOXIC EPIDERMAL NECROLYSIS 80 0.0053
149 TONGUE OEDEMA 20 0.0052
150 HYPOVENTILATION 17 0.0052
151 ATELECTASIS 49 0.0051
152 KLEBSIELLA INFECTION 25 0.0049
153 LUNG OPACITY 13 0.0049
154 SOFT TISSUE INFECTION 9 0.0049
155 TORSADE DE POINTES 38 0.0048
156 END STAGE RENAL DISEASE 88 0.0048
157 VENA CAVA THROMBOSIS 8 0.0048
158 STRESS CARDIOMYOPATHY 28 0.0048
159 BUNDLE BRANCH BLOCK RIGHT 22 0.0048
160 SHOCK HAEMORRHAGIC 39 0.0048
161 STAPHYLOCOCCUS TEST POSITIVE 10 0.0047
162 WOUND DEHISCENCE 16 0.0047
163 EXCORIATION 12 0.0047
164 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 11 0.0047
165 BACTERIAL INFECTION 88 0.0047
166 EOSINOPHILIA 82 0.0047
167 CHOREA 8 0.0046
168 BLOOD PRESSURE SYSTOLIC DECREASED 21 0.0046
169 FUNGAL PERITONITIS 7 0.0046
170 PERICARDIAL HAEMORRHAGE 10 0.0046
171 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 7 0.0046
172 PNEUMONIA FUNGAL 18 0.0046
173 LOW BIRTH WEIGHT BABY 36 0.0045
174 RENAL TUBULAR NECROSIS 44 0.0045
175 MEGACOLON 7 0.0045
176 APLASTIC ANAEMIA 23 0.0044
177 ANAPHYLACTOID REACTION 18 0.0044
178 PNEUMONIA KLEBSIELLA 8 0.0043
179 PREMATURE DELIVERY 69 0.0043
180 APPENDICITIS PERFORATED 11 0.0043
181 TRANSPLANT REJECTION 34 0.0042
182 MUCORMYCOSIS 11 0.0042
183 BACTERAEMIA 50 0.0042
184 KIDNEY TRANSPLANT REJECTION 20 0.0042
185 PARAPLEGIA 12 0.0042
186 HEPATITIS CHOLESTATIC 25 0.0041
187 OCULAR HYPERTENSION 8 0.0041
188 ELECTROENCEPHALOGRAM ABNORMAL 13 0.0041
189 PATHOGEN RESISTANCE 37 0.0041
190 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
191 VENTRICULAR FIBRILLATION 45 0.0040
192 BLOOD CREATININE ABNORMAL 14 0.0040
193 STUPOR 13 0.0040
194 LEUKOCYTOSIS 73 0.0040
195 TUBULOINTERSTITIAL NEPHRITIS 75 0.0040
196 ORGAN FAILURE 16 0.0040
197 VASCULAR DEVICE INFECTION 18 0.0040
198 DEVICE RELATED INFECTION 61 0.0040
199 MACULAR OEDEMA 22 0.0039
200 RASH MACULO-PAPULAR 87 0.0039
201 VENTRICULAR TACHYCARDIA 64 0.0039
202 PROTHROMBIN TIME PROLONGED 23 0.0038
203 CARDIOGENIC SHOCK 55 0.0038
204 WOUND SECRETION 15 0.0038
205 ESSENTIAL HYPERTENSION 7 0.0038
206 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 19 0.0037
207 ENTEROCOCCAL INFECTION 18 0.0037
208 SACROILIITIS 7 0.0037
209 OLIGURIA 23 0.0037
210 GENERALISED ERYTHEMA 21 0.0037
211 EMBOLIC STROKE 13 0.0037
212 BLOOD CULTURE POSITIVE 11 0.0037
213 HYDROCEPHALUS 20 0.0037
214 MIXED LIVER INJURY 11 0.0037
215 SUBDURAL HAEMORRHAGE 10 0.0037
216 RETROPERITONEAL HAEMORRHAGE 9 0.0036
217 STAPHYLOCOCCAL SEPSIS 18 0.0036
218 CIRCULATORY COLLAPSE 62 0.0036
219 THROMBOPHLEBITIS SUPERFICIAL 11 0.0036
220 ENDOTRACHEAL INTUBATION 10 0.0036
221 HYPOTHERMIA 36 0.0036
222 PREMATURE BABY 107 0.0036
223 CLOSTRIDIAL INFECTION 12 0.0035
224 DIABETIC RETINOPATHY 12 0.0035
225 TACHYPNOEA 48 0.0035
226 SEDATION COMPLICATION 9 0.0035
227 PROCEDURAL COMPLICATION 27 0.0035
228 POST PROCEDURAL COMPLICATION 67 0.0035
229 HYPOPNOEA 12 0.0035
230 VENTRICULAR HYPOKINESIA 11 0.0034
231 DISSEMINATED INTRAVASCULAR COAGULATION 48 0.0034
232 NECROTISING FASCIITIS 12 0.0034
233 INJURY 239 0.0034
234 LIVER ABSCESS 11 0.0034
235 ACUTE PULMONARY OEDEMA 19 0.0034
236 HYPOXIA 119 0.0034
237 THROMBOSIS IN DEVICE 11 0.0034
238 CELLULITIS 169 0.0034
239 HAEMOLYTIC ANAEMIA 30 0.0033
240 SUBARACHNOID HAEMORRHAGE 34 0.0033
241 THYROIDITIS 10 0.0033
242 PROCEDURAL HAEMORRHAGE 13 0.0033
243 DRUG-INDUCED LIVER INJURY 104 0.0033
244 LIP OEDEMA 14 0.0033
245 FOETAL DISTRESS SYNDROME 7 0.0033
246 IRITIS 10 0.0033
247 METABOLIC ACIDOSIS 105 0.0033
248 RENAL FAILURE 436 0.0033
249 AZOTAEMIA 13 0.0033
250 HYPOVOLAEMIA 19 0.0032
251 EXPOSED BONE IN JAW 7 0.0032
252 APNOEA 25 0.0032
253 CEREBELLAR SYNDROME 7 0.0032
254 SYSTEMIC CANDIDA 8 0.0032
255 TOXIC SKIN ERUPTION 32 0.0032
256 ACUTE HEPATIC FAILURE 43 0.0031
257 SINUS TACHYCARDIA 44 0.0031
258 BLOOD LOSS ANAEMIA 7 0.0031
259 VENTRICULAR DYSFUNCTION 8 0.0031
260 LARYNGEAL OEDEMA 19 0.0031
261 GENERALISED TONIC-CLONIC SEIZURE 51 0.0031
262 PERITONITIS BACTERIAL 31 0.0031
263 ENCEPHALOPATHY 75 0.0031
264 PURULENT DISCHARGE 13 0.0030
265 DEAFNESS NEUROSENSORY 10 0.0030
266 UNEVALUABLE EVENT 230 0.0030
267 HYPERVOLAEMIA 15 0.0030
268 SEROTONIN SYNDROME 58 0.0030
269 MYOCLONUS 36 0.0030
270 ARTHRITIS INFECTIVE 14 0.0030
271 PEPTIC ULCER 10 0.0030
272 RESPIRATORY DISTRESS 83 0.0030
273 POST PROCEDURAL HAEMORRHAGE 35 0.0030
274 STAPHYLOCOCCAL INFECTION 99 0.0030
275 ARTERIOSPASM CORONARY 12 0.0030
276 ESCHERICHIA BACTERAEMIA 7 0.0030
277 DUODENAL ULCER 21 0.0030
278 LARYNGOSPASM 8 0.0030
279 PULSE ABSENT 14 0.0029
280 STATUS EPILEPTICUS 33 0.0029
281 PREMATURE RUPTURE OF MEMBRANES 7 0.0029
282 HAND DEFORMITY 38 0.0029
283 CARDIAC ARREST 239 0.0029
284 CHRONIC KIDNEY DISEASE 218 0.0029
285 RESPIRATORY RATE DECREASED 9 0.0029
286 GLOMERULONEPHRITIS 7 0.0029
287 BILE DUCT STONE 9 0.0028
288 POSTOPERATIVE WOUND INFECTION 19 0.0028
289 HYPOTENSION 563 0.0028
290 CONJUNCTIVAL HYPERAEMIA 10 0.0028
291 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
292 LUMBAR SPINAL STENOSIS 8 0.0027
293 NOCARDIOSIS 7 0.0027
294 CARDIAC TAMPONADE 13 0.0027
295 FACE OEDEMA 46 0.0027
296 INTERNATIONAL NORMALISED RATIO INCREASED 77 0.0027
297 FUNGAL INFECTION 90 0.0027
298 COMPARTMENT SYNDROME 7 0.0027
299 HYPERCAPNIA 8 0.0027
300 PNEUMOTHORAX 42 0.0026
301 ECCHYMOSIS 18 0.0026
302 SEPTIC SHOCK 114 0.0026
303 HEPATITIS ACUTE 17 0.0026
304 MASTICATION DISORDER 8 0.0026
305 RENAL FAILURE ACUTE 110 0.0026
306 MULTIPLE-DRUG RESISTANCE 8 0.0026
307 HEPATIC ENCEPHALOPATHY 24 0.0026
308 THROMBOTIC MICROANGIOPATHY 25 0.0026
309 ANURIA 22 0.0026
310 ESCHERICHIA INFECTION 21 0.0026
311 JAUNDICE CHOLESTATIC 9 0.0025
312 SHOCK 58 0.0025
313 ACUTE KIDNEY INJURY 385 0.0025
314 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 24 0.0025
315 SERUM SICKNESS 7 0.0025
316 SPINAL OSTEOARTHRITIS 22 0.0025
317 LUNG CONSOLIDATION 7 0.0025
318 HAEMODIALYSIS 21 0.0025
319 CANDIDA INFECTION 42 0.0025
320 PURPURA 22 0.0025
321 RENAL IMPAIRMENT 207 0.0025
322 VENTRICULAR ARRHYTHMIA 9 0.0025
323 THROMBOCYTOSIS 9 0.0025
324 PSEUDOMONAS INFECTION 21 0.0024
325 PULMONARY HAEMORRHAGE 19 0.0024
326 CHRONIC SINUSITIS 9 0.0024
327 TOXIC ENCEPHALOPATHY 12 0.0024
328 RESPIRATORY DEPRESSION 29 0.0024
329 PLEURISY 14 0.0024
330 BRADYCARDIA 125 0.0024
331 HEPATIC CYTOLYSIS 30 0.0024
332 PHLEBITIS 12 0.0023
333 RENAL FAILURE CHRONIC 18 0.0023
334 CENTRAL VENOUS CATHETERISATION 7 0.0023
335 PERIORBITAL OEDEMA 12 0.0023
336 HYPERREFLEXIA 8 0.0023
337 SUBCUTANEOUS ABSCESS 11 0.0023
338 URINE OUTPUT DECREASED 20 0.0023
339 RIGHT VENTRICULAR FAILURE 16 0.0023
340 ANGIOEDEMA 101 0.0023
341 WOUND INFECTION 25 0.0023
342 PATENT DUCTUS ARTERIOSUS 9 0.0023
343 TACHYCARDIA 201 0.0023
344 GENERALISED OEDEMA 28 0.0023
345 NYSTAGMUS 12 0.0023
346 CHOLESTASIS 43 0.0022
347 VENOOCCLUSIVE LIVER DISEASE 11 0.0022
348 ACIDOSIS 17 0.0022
349 OSTEOMYELITIS 40 0.0022
350 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 9 0.0022
351 DERMATITIS EXFOLIATIVE 11 0.0022
352 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
353 ACUTE RESPIRATORY FAILURE 42 0.0022
354 UROSEPSIS 20 0.0022
355 EOSINOPHIL COUNT INCREASED 18 0.0022
356 STEVENS-JOHNSON SYNDROME 48 0.0022
357 CLOSTRIDIUM DIFFICILE INFECTION 47 0.0022
358 BACTERIAL SEPSIS 7 0.0021
359 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
360 DRUG ERUPTION 38 0.0021
361 UPPER GASTROINTESTINAL HAEMORRHAGE 36 0.0021
362 PULMONARY ALVEOLAR HAEMORRHAGE 12 0.0021
363 UNRESPONSIVE TO STIMULI 55 0.0021
364 HAEMATOMA 55 0.0021
365 CARDIOMEGALY 26 0.0021
366 TROPONIN INCREASED 16 0.0021
367 SINUS BRADYCARDIA 20 0.0021
368 RASH VESICULAR 10 0.0021
369 DERMATITIS ALLERGIC 26 0.0021
370 RALES 12 0.0021
371 RESPIRATORY FAILURE 149 0.0020
372 VENOUS THROMBOSIS 8 0.0020
373 NORMAL NEWBORN 11 0.0020
374 POOR QUALITY DRUG ADMINISTERED 13 0.0020
375 CEREBRAL ATROPHY 8 0.0020
376 INTESTINAL ISCHAEMIA 11 0.0020
377 GANGRENE 12 0.0020
378 OXYGEN SATURATION DECREASED 111 0.0020
379 PANCYTOPENIA 110 0.0020
380 PRODUCT CONTAMINATION 7 0.0020
381 HYPERTHERMIA 15 0.0020
382 PNEUMONIA BACTERIAL 18 0.0020
383 ISCHAEMIA 9 0.0020
384 CHOLECYSTITIS ACUTE 11 0.0019
385 PERIPHERAL VASCULAR DISORDER 10 0.0019
386 BONE LESION 7 0.0019
387 NEUTROPHILIA 11 0.0019
388 LUNG INFILTRATION 17 0.0019
389 FLUID OVERLOAD 28 0.0019
390 CONGESTIVE CARDIOMYOPATHY 8 0.0019
391 BLOOD PRESSURE DECREASED 127 0.0019
392 HYPERKALAEMIA 67 0.0019
393 PARADOXICAL DRUG REACTION 7 0.0019
394 BRAIN OEDEMA 24 0.0019
395 ELECTROLYTE IMBALANCE 22 0.0019
396 CARDIO-RESPIRATORY ARREST 79 0.0019
397 BLOOD CREATININE INCREASED 123 0.0019
398 MENTAL STATUS CHANGES 52 0.0019
399 DIVERTICULUM INTESTINAL 8 0.0018
400 PULMONARY HYPERTENSION 38 0.0018
401 SMALL FOR DATES BABY 9 0.0018
402 HAEMOLYSIS 14 0.0018
403 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
404 PHYSICAL DISABILITY 8 0.0018
405 EYELID OEDEMA 21 0.0018
406 ILEUS PARALYTIC 8 0.0018
407 HYPOKALAEMIA 82 0.0018
408 ORAL DISORDER 13 0.0018
409 EXPOSURE DURING PREGNANCY 110 0.0018
410 PERIORBITAL SWELLING 10 0.0018
411 ATRIAL FLUTTER 14 0.0018
412 IMMUNE THROMBOCYTOPENIA 8 0.0017
413 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
414 PETECHIAE 18 0.0017
415 HEPATITIS 44 0.0017
416 MYDRIASIS 22 0.0017
417 PERIPHERAL ISCHAEMIA 7 0.0017
418 HYPERTENSIVE CRISIS 19 0.0017
419 DECREASED INTEREST 10 0.0017
420 BLOOD ALKALINE PHOSPHATASE INCREASED 42 0.0017
421 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
422 DRUG RESISTANCE 43 0.0017
423 HYPOVOLAEMIC SHOCK 8 0.0017
424 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
425 FAECAL INCONTINENCE 8 0.0017
426 URTICARIA 278 0.0017
427 FOETAL EXPOSURE DURING PREGNANCY 134 0.0016
428 ABSCESS LIMB 7 0.0016
429 LEFT VENTRICULAR DYSFUNCTION 11 0.0016
430 RENAL CYST 13 0.0016
431 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
432 EMOTIONAL DISTRESS 198 0.0016
433 ABSCESS 26 0.0016
434 PLEURAL EFFUSION 99 0.0016
435 CYTOMEGALOVIRUS INFECTION 27 0.0016
436 HEPATOCELLULAR INJURY 23 0.0016
437 CARDIAC MURMUR 14 0.0016
438 AGRANULOCYTOSIS 30 0.0016
439 ERYTHEMA MULTIFORME 15 0.0016
440 RESPIRATION ABNORMAL 11 0.0016
441 PREMATURE LABOUR 9 0.0016
442 POLYURIA 13 0.0016
443 EMPHYSEMA 16 0.0016
444 PERONEAL NERVE PALSY 9 0.0016
445 ALANINE AMINOTRANSFERASE INCREASED 97 0.0016
446 PATHOLOGICAL FRACTURE 8 0.0016
447 NEUROLOGICAL SYMPTOM 9 0.0016
448 RHINITIS ALLERGIC 7 0.0016
449 SPINAL COMPRESSION FRACTURE 13 0.0016
450 MYOCARDITIS 18 0.0016
451 PAPULE 11 0.0016
452 JAUNDICE 42 0.0016
453 FEMORAL NECK FRACTURE 8 0.0016
454 ENTEROCOLITIS 9 0.0016
455 CEREBRAL ISCHAEMIA 8 0.0016
456 ASPIRATION 17 0.0016
457 THERMAL BURN 11 0.0015
458 PERITONITIS 32 0.0015
459 DEPRESSED LEVEL OF CONSCIOUSNESS 61 0.0015
460 DRUG INTERACTION 244 0.0015
461 DERMATITIS BULLOUS 11 0.0015
462 GRAND MAL CONVULSION 14 0.0015
463 HYPOPHOSPHATAEMIA 11 0.0015
464 DERMATITIS ACNEIFORM 9 0.0015
465 SEPSIS 164 0.0015
466 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
467 HYDRONEPHROSIS 11 0.0015
468 HIATUS HERNIA 19 0.0015
469 CHOLELITHIASIS 48 0.0015
470 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
471 ILEUS 18 0.0014
472 NECROSIS 8 0.0014
473 HYPOMAGNESAEMIA 20 0.0014
474 RENAL CELL CARCINOMA 7 0.0014
475 ASPARTATE AMINOTRANSFERASE INCREASED 76 0.0014
476 BONE MARROW FAILURE 29 0.0014
477 BONE DISORDER 26 0.0014
478 CONTRAINDICATED PRODUCT ADMINISTERED 43 0.0014
479 DIALYSIS 20 0.0014
480 PULMONARY OEDEMA 63 0.0014
481 HAEMORRHAGE INTRACRANIAL 21 0.0014
482 DEEP VEIN THROMBOSIS 91 0.0014
483 HYPERAMMONAEMIA 7 0.0014
484 RHABDOMYOLYSIS 58 0.0014
485 TRICUSPID VALVE INCOMPETENCE 11 0.0014
486 PERICARDIAL EFFUSION 32 0.0014
487 ARTERIOSCLEROSIS 13 0.0014
488 THROMBOCYTOPENIA 154 0.0014
489 CAESAREAN SECTION 16 0.0014
490 HAEMATOCRIT DECREASED 27 0.0014
491 RESPIRATORY RATE INCREASED 12 0.0014
492 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
493 MALNUTRITION 15 0.0013
494 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
495 SKIN INFECTION 15 0.0013
496 PARTIAL SEIZURES 7 0.0013
497 NEPHROPATHY TOXIC 15 0.0013
498 CYANOSIS 21 0.0013
499 PHARYNGEAL SWELLING 13 0.0013
500 DELIRIUM 46 0.0013
501 MATERNAL EXPOSURE DURING PREGNANCY 118 0.0013
502 DERMATITIS CONTACT 15 0.0013
503 LYMPHOCYTE COUNT DECREASED 23 0.0013
504 SALIVARY HYPERSECRETION 13 0.0013
505 RASH ERYTHEMATOUS 62 0.0013
506 HYPERTRANSAMINASAEMIA 9 0.0013
507 LIP SWELLING 43 0.0013
508 HYPOALBUMINAEMIA 10 0.0013
509 GASTRIC ULCER HAEMORRHAGE 7 0.0013
510 LEUKOPENIA 63 0.0013
511 CHOLECYSTITIS 15 0.0013
512 NEUROTOXICITY 22 0.0013
513 BLOOD UREA INCREASED 21 0.0013
514 OSTEOPENIA 19 0.0013
515 C-REACTIVE PROTEIN ABNORMAL 8 0.0012
516 DIZZINESS POSTURAL 12 0.0012
517 RASH PUSTULAR 9 0.0012
518 CEREBRAL HAEMORRHAGE 44 0.0012
519 DECUBITUS ULCER 10 0.0012
520 ACUTE MYOCARDIAL INFARCTION 36 0.0012
521 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
522 DRUG LEVEL INCREASED 20 0.0012
523 EXOSTOSIS 11 0.0012
524 HYPOTONIA 12 0.0012
525 VASCULITIS 14 0.0012
526 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
527 ECONOMIC PROBLEM 18 0.0012
528 ODYNOPHAGIA 7 0.0012
529 LACERATION 11 0.0012
530 BLOOD BILIRUBIN INCREASED 31 0.0011
531 HAEMATEMESIS 29 0.0011
532 RASH PRURITIC 62 0.0011
533 LIVER INJURY 28 0.0011
534 GROIN PAIN 10 0.0011
535 MELAENA 25 0.0011
536 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
537 HYPERCALCAEMIA 14 0.0011
538 MIOSIS 9 0.0011
539 SWOLLEN TONGUE 35 0.0011
540 HEPATOMEGALY 11 0.0011
541 JOINT RANGE OF MOTION DECREASED 15 0.0011
542 ERYTHEMA 229 0.0011
543 URINARY INCONTINENCE 33 0.0011
544 LIGAMENT SPRAIN 11 0.0011
545 ANAL INCONTINENCE 10 0.0011
546 PYREXIA 383 0.0011
547 POST PROCEDURAL INFECTION 9 0.0011
548 CEREBRAL INFARCTION 27 0.0011
549 SKIN LACERATION 12 0.0011
550 WHITE BLOOD CELL COUNT INCREASED 42 0.0011
551 INFECTION 158 0.0011
552 MOUTH HAEMORRHAGE 8 0.0011
553 RASH 475 0.0011
554 HEMIPLEGIA 9 0.0011
555 HERPES SIMPLEX 7 0.0011
556 DEFORMITY 10 0.0011
557 ASPERGILLUS INFECTION 7 0.0011
558 HYPOGAMMAGLOBULINAEMIA 7 0.0011
559 HEMIPARESIS 18 0.0011
560 MITRAL VALVE INCOMPETENCE 12 0.0011
561 FACIAL PARALYSIS 9 0.0011
562 OSTEONECROSIS OF JAW 26 0.0010
563 LACTIC ACIDOSIS 34 0.0010
564 MENINGITIS 7 0.0010
565 ANXIETY 297 0.0010
566 PSYCHOLOGICAL TRAUMA 9 0.0010
567 MYOPATHY 9 0.0010
568 ATRIOVENTRICULAR BLOCK 8 0.0010
569 ANAEMIA 196 0.0010
570 SPLENOMEGALY 12 0.0010
571 TUMOUR LYSIS SYNDROME 9 0.0010
572 ASCITES 30 0.0010
573 HEPATIC FUNCTION ABNORMAL 38 0.0010
574 RESPIRATORY ARREST 28 0.0010
575 OEDEMA 55 0.0010
576 BLOOD ALBUMIN DECREASED 8 0.0010
577 HYPERLIPIDAEMIA 12 0.0010
578 RASH GENERALISED 26 0.0010
579 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
580 SENSORY DISTURBANCE 16 0.0010
581 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
582 MUCOSAL INFLAMMATION 26 0.0010
583 HAEMATURIA 34 0.0010
584 URINARY RETENTION 33 0.0010
585 LYMPHADENOPATHY 35 0.0010
586 ATRIAL FIBRILLATION 96 0.0010
587 NO THERAPEUTIC RESPONSE 12 0.0010
588 SMALL INTESTINAL OBSTRUCTION 12 0.0010
589 BLOOD CREATINE PHOSPHOKINASE INCREASED 28 0.0010
590 RIB FRACTURE 20 0.0010
591 PRURITUS GENERALISED 21 0.0010
592 RESPIRATORY DISORDER 29 0.0010
593 MYOCARDIAL ISCHAEMIA 11 0.0010
594 HEPATIC STEATOSIS 18 0.0010
595 NEPHROPATHY 9 0.0010
596 EMBOLISM 8 0.0010
597 VENTRICULAR EXTRASYSTOLES 10 0.0010
598 DISABILITY 19 0.0010
599 FLANK PAIN 9 0.0010
600 PSYCHIATRIC SYMPTOM 7 0.0009
601 BLISTER 53 0.0009
602 OSTEOARTHRITIS 40 0.0009
603 HEPATIC FAILURE 28 0.0009
604 PULMONARY EMBOLISM 88 0.0009
605 PYELONEPHRITIS 8 0.0009
606 VITAMIN D DEFICIENCY 9 0.0009
607 TOOTH LOSS 19 0.0009
608 OESOPHAGITIS 10 0.0009
609 PANCREATITIS 48 0.0009
610 TOOTH FRACTURE 10 0.0009
611 BURSITIS 11 0.0009
612 HYPERGLYCAEMIA 33 0.0009
613 MEDICATION ERROR 50 0.0009
614 EYE HAEMORRHAGE 12 0.0009
615 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
616 GASTRIC ULCER 17 0.0009
617 EYELID PTOSIS 9 0.0009
618 RHEUMATOID ARTHRITIS 99 0.0009
619 THERAPY NON-RESPONDER 39 0.0009
620 ARTHROPATHY 48 0.0009
621 TRANSFUSION 9 0.0009
622 HAEMOGLOBIN DECREASED 88 0.0009
623 HEPATOTOXICITY 19 0.0009
624 METASTASES TO BONE 14 0.0009
625 C-REACTIVE PROTEIN INCREASED 31 0.0009
626 SKIN ULCER 22 0.0009
627 ORAL PAIN 19 0.0008
628 HYPOCALCAEMIA 16 0.0008
629 ACUTE CORONARY SYNDROME 7 0.0008
630 PROTEINURIA 16 0.0008
631 PNEUMONIA ASPIRATION 21 0.0008
632 ISCHAEMIC STROKE 15 0.0008
633 MUSCLE RIGIDITY 10 0.0008
634 ORAL CANDIDIASIS 11 0.0008
635 PULMONARY CONGESTION 11 0.0008
636 BODY TEMPERATURE INCREASED 17 0.0008
637 GLAUCOMA 16 0.0008
638 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
639 CHILLS 97 0.0008
640 DYSTONIA 16 0.0008
641 MUSCLE TWITCHING 19 0.0008
642 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
643 DRUG EXPOSURE DURING PREGNANCY 28 0.0008
644 SKIN HYPERPIGMENTATION 7 0.0008
645 DENTAL CARIES 9 0.0008
646 PAIN IN JAW 23 0.0008
647 TRANSAMINASES INCREASED 18 0.0008
648 BLADDER DISORDER 8 0.0008
649 INTESTINAL PERFORATION 9 0.0008
650 BLOOD CALCIUM DECREASED 9 0.0008
651 HYPONATRAEMIA 45 0.0008
652 GASTRITIS 21 0.0008
653 BRAIN INJURY 8 0.0008
654 RESTLESSNESS 29 0.0008
655 HYPOPHAGIA 20 0.0008
656 NEUTROPHIL COUNT INCREASED 8 0.0008
657 HYPERBILIRUBINAEMIA 8 0.0008
658 SUBDURAL HAEMATOMA 11 0.0008
659 ATAXIA 9 0.0008
660 HALLUCINATION, VISUAL 16 0.0008
661 JOINT DISLOCATION 8 0.0008
662 FEBRILE NEUTROPENIA 50 0.0008
663 HAEMOPTYSIS 21 0.0008
664 LETHARGY 43 0.0007
665 RASH MACULAR 26 0.0007
666 WHEEZING 44 0.0007
667 PALLOR 20 0.0007
668 DRUG TOXICITY 10 0.0007
669 MUSCLE SPASTICITY 9 0.0007
670 BONE LOSS 11 0.0007
671 OSTEOPOROSIS 30 0.0007
672 APHASIA 22 0.0007
673 THIRST 13 0.0007
674 HAEMORRHAGE 76 0.0007
675 HEART RATE INCREASED 72 0.0007
676 PRODUCT USE IN UNAPPROVED INDICATION 180 0.0007
677 PROCEDURAL PAIN 20 0.0007
678 AUTOIMMUNE DISORDER 7 0.0007
679 OEDEMA PERIPHERAL 87 0.0007
680 THYROID DISORDER 11 0.0007
681 PANCREATITIS ACUTE 16 0.0007
682 BODY TEMPERATURE DECREASED 7 0.0007
683 FEMUR FRACTURE 22 0.0007
684 SWELLING FACE 46 0.0007
685 NERVOUS SYSTEM DISORDER 22 0.0007
686 PLATELET COUNT DECREASED 75 0.0007
687 ABDOMINAL DISCOMFORT 118 0.0007
688 SCAR 12 0.0007
689 GASTROOESOPHAGEAL REFLUX DISEASE 56 0.0007
690 SKIN LESION 19 0.0007
691 NEUTROPENIA 94 0.0007
692 MOTOR DYSFUNCTION 7 0.0007
693 HEART RATE DECREASED 24 0.0007
694 CONVULSION 39 0.0007
695 SLEEP APNOEA SYNDROME 13 0.0007
696 ADVERSE REACTION 9 0.0007
697 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
698 COVID-19 PNEUMONIA 8 0.0007
699 SKELETAL INJURY 7 0.0007
700 POOR VENOUS ACCESS 7 0.0007
701 ARRHYTHMIA 32 0.0007
702 FOLLICULITIS 7 0.0007
703 CHROMATURIA 15 0.0007
704 DYSARTHRIA 25 0.0007
705 EPILEPSY 20 0.0007
706 AGITATION 48 0.0007
707 LIVER FUNCTION TEST INCREASED 14 0.0007
708 CYTOKINE RELEASE SYNDROME 13 0.0006
709 MASS 9 0.0006
710 OSTEONECROSIS 21 0.0006
711 CONFUSIONAL STATE 103 0.0006
712 PAIN 389 0.0006
713 HYPERSENSITIVITY 117 0.0006
714 NERVE INJURY 7 0.0006
715 ANGINA PECTORIS 18 0.0006
716 HYPERTENSION 133 0.0006
717 INTRAOCULAR PRESSURE INCREASED 8 0.0006
718 INFUSION SITE PAIN 8 0.0006
719 DERMATITIS 13 0.0006
720 PHARMACEUTICAL PRODUCT COMPLAINT 16 0.0006
721 BLOOD POTASSIUM INCREASED 10 0.0006
722 HAEMORRHOIDS 12 0.0006
723 LIMB DISCOMFORT 19 0.0006
724 DYSPNOEA EXERTIONAL 23 0.0006
725 IMPAIRED HEALING 20 0.0006
726 COLITIS 23 0.0006
727 ABDOMINAL PAIN 139 0.0006
728 HYPOAESTHESIA ORAL 9 0.0006
729 LIMB INJURY 16 0.0006
730 GASTROINTESTINAL HAEMORRHAGE 49 0.0006
731 PHARYNGEAL OEDEMA 9 0.0006
732 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
733 BLOOD SODIUM DECREASED 11 0.0006
734 ANKLE FRACTURE 9 0.0006
735 DISORIENTATION 23 0.0006
736 ADRENAL INSUFFICIENCY 7 0.0006
737 CONDITION AGGRAVATED 175 0.0006
738 ORTHOSTATIC HYPOTENSION 10 0.0006
739 CYTOPENIA 7 0.0006
740 DYSURIA 21 0.0006
741 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
742 DEPRESSION 129 0.0006
743 DYSKINESIA 23 0.0006
744 BLOOD POTASSIUM DECREASED 17 0.0006
745 OBESITY 9 0.0006
746 NEUTROPHIL COUNT DECREASED 23 0.0006
747 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
748 LOSS OF CONSCIOUSNESS 72 0.0006
749 GALLBLADDER DISORDER 10 0.0006
750 RED BLOOD CELL COUNT DECREASED 16 0.0006
751 BLOOD PRESSURE ABNORMAL 11 0.0006
752 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
753 DYSPHAGIA 52 0.0005
754 PHOTOSENSITIVITY REACTION 9 0.0005
755 ANOREXIA 7 0.0005
756 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
757 INTERSTITIAL LUNG DISEASE 26 0.0005
758 PLATELET COUNT INCREASED 7 0.0005
759 HEPATIC ENZYME INCREASED 36 0.0005
760 CARDIAC FAILURE 42 0.0005
761 LOCAL SWELLING 9 0.0005
762 URINARY TRACT INFECTION 88 0.0005
763 HYPOGLYCAEMIA 25 0.0005
764 HYPERHIDROSIS 66 0.0005
765 ORAL HERPES 10 0.0005
766 PNEUMONIA 165 0.0005
767 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
768 EPISTAXIS 38 0.0005
769 HEAD INJURY 16 0.0005
770 GENERAL PHYSICAL HEALTH DETERIORATION 58 0.0005
771 HIP FRACTURE 16 0.0005
772 LOCALISED INFECTION 12 0.0005
773 NEUROPATHY PERIPHERAL 47 0.0005
774 PRURITUS 188 0.0005
775 RECTAL HAEMORRHAGE 21 0.0005
776 MANIA 8 0.0005
777 PARAESTHESIA ORAL 7 0.0005
778 HYPERTHYROIDISM 7 0.0005
779 HYPOKINESIA 7 0.0005
780 VOMITING 226 0.0005
781 TINNITUS 22 0.0005
782 EYE PAIN 27 0.0005
783 DYSPNOEA 270 0.0005
784 CHEST PAIN 88 0.0005
785 FOOT FRACTURE 9 0.0005
786 MOUTH ULCERATION 10 0.0005
787 CARDIOMYOPATHY 7 0.0005
788 LIVER DISORDER 21 0.0005
789 FEELING HOT 29 0.0005
790 DRUG INEFFECTIVE 623 0.0005
791 TREATMENT FAILURE 39 0.0005
792 PULMONARY MASS 7 0.0005
793 ADVERSE EVENT 43 0.0005
794 NECK PAIN 26 0.0005
795 WOUND 13 0.0005
796 DISEASE RECURRENCE 22 0.0005
797 CORONARY ARTERY DISEASE 14 0.0005
798 SEDATION 12 0.0005
799 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
800 METASTASES TO LIVER 8 0.0005
801 NEURALGIA 11 0.0005
802 EJECTION FRACTION DECREASED 7 0.0004
803 SKIN EXFOLIATION 38 0.0004
804 SYNCOPE 45 0.0004
805 BONE DENSITY DECREASED 14 0.0004
806 SNEEZING 10 0.0004
807 BRONCHITIS 33 0.0004
808 BACK PAIN 103 0.0004
809 CHEST DISCOMFORT 45 0.0004
810 INFUSION RELATED REACTION 29 0.0004
811 FLUSHING 44 0.0004
812 POLLAKIURIA 18 0.0004
813 SWELLING 40 0.0004
814 BONE PAIN 25 0.0004
815 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
816 NERVOUSNESS 22 0.0004
817 MUSCULOSKELETAL PAIN 22 0.0004
818 PULMONARY FIBROSIS 8 0.0004
819 SEIZURE 48 0.0004
820 NEPHROLITHIASIS 19 0.0004
821 MUSCULAR WEAKNESS 47 0.0004
822 BURNING SENSATION 29 0.0004
823 PARAESTHESIA 65 0.0004
824 CARDIAC FAILURE CONGESTIVE 33 0.0004
825 LUNG DISORDER 20 0.0004
826 THROAT TIGHTNESS 11 0.0004
827 PARANOIA 7 0.0004
828 ABDOMINAL DISTENSION 42 0.0004
829 RASH PAPULAR 9 0.0004
830 SPINAL FRACTURE 8 0.0004
831 COLD SWEAT 7 0.0004
832 CEREBROVASCULAR ACCIDENT 67 0.0004
833 PRODUCT AVAILABILITY ISSUE 9 0.0004
834 CARDIOVASCULAR DISORDER 10 0.0004
835 OFF LABEL USE 343 0.0004
836 ERECTILE DYSFUNCTION 10 0.0004
837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
838 DEAFNESS 10 0.0004
839 DEHYDRATION 51 0.0004
840 FALL 127 0.0004
841 TOXICITY TO VARIOUS AGENTS 64 0.0004
842 IMPAIRED WORK ABILITY 8 0.0004
843 NAUSEA 295 0.0004
844 GAIT DISTURBANCE 71 0.0004
845 INFLAMMATION 19 0.0004
846 BLINDNESS 15 0.0004
847 PNEUMONITIS 10 0.0004
848 PRODUCT PRESCRIBING ISSUE 8 0.0004
849 EAR PAIN 7 0.0004
850 COMA 17 0.0004
851 PRODUCTIVE COUGH 17 0.0004
852 SINUS DISORDER 7 0.0004
853 STOMATITIS 21 0.0003
854 HYPOTHYROIDISM 11 0.0003
855 CONSTIPATION 75 0.0003
856 TREMOR 57 0.0003
857 SOMNOLENCE 69 0.0003
858 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
859 DIABETES MELLITUS 26 0.0003
860 HOSPITALISATION 52 0.0003
861 THROMBOSIS 27 0.0003
862 DISTURBANCE IN ATTENTION 18 0.0003
863 BLOOD PRESSURE FLUCTUATION 8 0.0003
864 VISUAL ACUITY REDUCED 11 0.0003
865 VIRAL INFECTION 11 0.0003
866 PRESYNCOPE 8 0.0003
867 SKIN DISCOLOURATION 15 0.0003
868 FEELING COLD 9 0.0003
869 RENAL DISORDER 15 0.0003
870 MENTAL DISORDER 14 0.0003
871 INTESTINAL OBSTRUCTION 12 0.0003
872 DISCOMFORT 19 0.0003
873 LIVER FUNCTION TEST ABNORMAL 9 0.0003
874 DIPLOPIA 8 0.0003
875 PSYCHOTIC DISORDER 9 0.0003
876 BLOOD PRESSURE INCREASED 46 0.0003
877 HYPOAESTHESIA 45 0.0003
878 ARTHRALGIA 125 0.0003
879 COGNITIVE DISORDER 14 0.0003
880 COUGH 84 0.0003
881 DEVICE DISLOCATION 13 0.0003
882 DIARRHOEA 193 0.0003
883 JOINT SWELLING 36 0.0003
884 LACRIMATION INCREASED 9 0.0003
885 DECREASED APPETITE 69 0.0003
886 EMOTIONAL DISORDER 9 0.0003
887 ROAD TRAFFIC ACCIDENT 12 0.0003
888 ASTHENIA 106 0.0003
889 PAIN IN EXTREMITY 83 0.0003
890 MOVEMENT DISORDER 9 0.0003
891 HALLUCINATION 21 0.0003
892 ABDOMINAL PAIN LOWER 7 0.0003
893 VISION BLURRED 38 0.0003
894 OCULAR HYPERAEMIA 13 0.0003
895 LABORATORY TEST ABNORMAL 8 0.0003
896 SKIN DISORDER 9 0.0003
897 ECZEMA 14 0.0003
898 SPEECH DISORDER 14 0.0003
899 MYALGIA 45 0.0003
900 DISEASE PROGRESSION 31 0.0003
901 AMNESIA 17 0.0003
902 DRUG ADMINISTRATION ERROR 8 0.0003
903 DRUG EFFECT DECREASED 14 0.0003
904 TREATMENT NONCOMPLIANCE 14 0.0003
905 FLUID RETENTION 13 0.0003
906 CYSTITIS 8 0.0003
907 BLOOD GLUCOSE DECREASED 12 0.0002
908 CONTUSION 24 0.0002
909 NIGHT SWEATS 8 0.0002
910 HERPES ZOSTER 14 0.0002
911 EYE DISORDER 8 0.0002
912 EYE SWELLING 9 0.0002
913 MYOCARDIAL INFARCTION 42 0.0002
914 PRODUCT USE ISSUE 45 0.0002
915 WITHDRAWAL SYNDROME 10 0.0002
916 TYPE 2 DIABETES MELLITUS 8 0.0002
917 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
918 HAEMATOCHEZIA 13 0.0002
919 CATARACT 14 0.0002
920 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
921 RHINORRHOEA 15 0.0002
922 MUSCULOSKELETAL STIFFNESS 20 0.0002
923 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
924 CARDIAC DISORDER 21 0.0002
925 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
926 DYSPEPSIA 22 0.0002
927 SKIN BURNING SENSATION 16 0.0002
928 GASTROINTESTINAL DISORDER 20 0.0002
929 THROAT IRRITATION 10 0.0002
930 NASAL CONGESTION 13 0.0002
931 DRY EYE 11 0.0002
932 AGGRESSION 11 0.0002
933 ACCIDENTAL OVERDOSE 8 0.0002
934 MUSCLE SPASMS 40 0.0002
935 ARTHRITIS 17 0.0002
936 DEATH 185 0.0002
937 GAIT INABILITY 7 0.0002
938 OVERDOSE 45 0.0002
939 DIZZINESS 104 0.0002
940 WEIGHT DECREASED 58 0.0002
941 DRUG INTOLERANCE 20 0.0002
942 MALAISE 90 0.0002
943 COLITIS ULCERATIVE 9 0.0002
944 PRODUCT DOSE OMISSION 13 0.0002
945 INFLUENZA 22 0.0002
946 PERIPHERAL SWELLING 30 0.0002
947 MYELOSUPPRESSION 7 0.0002
948 FLATULENCE 11 0.0002
949 BLOOD CHOLESTEROL INCREASED 9 0.0002
950 PANIC ATTACK 7 0.0002
951 HOT FLUSH 14 0.0002
952 IRRITABILITY 11 0.0002
953 THERAPEUTIC RESPONSE DECREASED 11 0.0002
954 MOBILITY DECREASED 13 0.0002
955 VERTIGO 11 0.0002
956 PLASMA CELL MYELOMA 7 0.0002
957 PALPITATIONS 21 0.0002
958 COVID-19 31 0.0002
959 ABNORMAL BEHAVIOUR 7 0.0002
960 SINUSITIS 18 0.0002
961 SURGERY 10 0.0002
962 SLEEP DISORDER 12 0.0002
963 HEADACHE 106 0.0002
964 INSOMNIA 45 0.0002
965 FATIGUE 131 0.0002
966 DRY MOUTH 13 0.0002
967 ASTHMA 18 0.0002
968 THERAPY CESSATION 8 0.0002
969 DYSPHONIA 9 0.0002
970 MEMORY IMPAIRMENT 21 0.0002
971 BALANCE DISORDER 13 0.0002
972 BLOOD GLUCOSE INCREASED 28 0.0001
973 DRUG WITHDRAWAL SYNDROME 13 0.0001
974 DEVICE MALFUNCTION 10 0.0001
975 ABDOMINAL PAIN UPPER 29 0.0001
976 PRODUCT QUALITY ISSUE 18 0.0001
977 VISUAL IMPAIRMENT 16 0.0001
978 ALOPECIA 25 0.0001
979 NO ADVERSE EVENT 23 0.0001
980 PSORIASIS 16 0.0001
981 INFLUENZA LIKE ILLNESS 10 0.0001
982 MIGRAINE 11 0.0001
983 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
984 WEIGHT INCREASED 25 0.0001
985 SUICIDAL IDEATION 10 0.0001
986 OROPHARYNGEAL PAIN 10 0.0001
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
988 ADVERSE DRUG REACTION 9 0.0001
989 FEELING ABNORMAL 23 0.0001
990 NASOPHARYNGITIS 17 0.0001
991 DRUG DEPENDENCE 11 0.0001
992 DRUG DOSE OMISSION 8 0.0000
993 PRODUCT DOSE OMISSION ISSUE 14 0.0000
994 INCORRECT DOSE ADMINISTERED 10 0.0000
995 INJECTION SITE PAIN 10 0.0000